{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:13:12Z","timestamp":1793293992177,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30-AR-069589"],"award-info":[{"award-number":["P30-AR-069589"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23-AR-068433"],"award-info":[{"award-number":["K23-AR-068433"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eli Lilly"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer Ingelheim"},{"name":"Janssen"},{"DOI":"10.13039\/100004336","name":"Novartis Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ortho Dermatologics"},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ortho Dermatologics"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jaad.2019.10.019","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T11:45:20Z","timestamp":1571139920000},"page":"1368-1375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Mental health impairment among children with atopic dermatitis: A United States population-based cross-sectional study of the 2013-2017 National Health Interview Survey"],"prefix":"10.1016","volume":"82","author":[{"given":"Joy","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2019.10.019_bib1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three","volume":"124","author":"Odhiambo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2019.10.019_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/DER.0000000000000034","article-title":"Associations of childhood eczema severity: a US population-based study","volume":"25","author":"Silverberg","year":"2014","journal-title":"Dermatitis"},{"issue":"1","key":"10.1016\/j.jaad.2019.10.019_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jid.2010.251","article-title":"Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health","volume":"131","author":"Shaw","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.10.019_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jid.2016.07.012","article-title":"The burden of atopic dermatitis: summary of a report for the National Eczema Association","volume":"137","author":"Drucker","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.10.019_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1542\/peds.2004-0374","article-title":"Effects of atopic dermatitis on young American children and their families","volume":"114","author":"Chamlin","year":"2004","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.jaad.2019.10.019_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2018.03.017","article-title":"Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta-analysis","volume":"79","author":"Ronnstad","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2019.10.019_bib7","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/jid.2015.337","article-title":"Association between atopic dermatitis and depression in US adults","volume":"135","author":"Yu","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.019_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/jamadermatol.2018.4566","article-title":"Association between atopic dermatitis and suicidality: a systematic review and meta-analysis","volume":"155","author":"Sandhu","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.019_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2012.10.041","article-title":"Mental health comorbidity in patients with atopic dermatitis","volume":"131","author":"Yaghmaie","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.jaad.2019.10.019_bib10","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jama.2009.136","article-title":"Atopic eczema and attention-deficit\/hyperactivity disorder in a population-based sample of children and adolescents","volume":"301","author":"Schmitt","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jaad.2019.10.019_bib11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/bjd.14697","article-title":"Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults","volume":"175","author":"Strom","year":"2016","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2019.10.019_bib12","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/jid.2014.70","article-title":"Suicidal ideation, mental health problems, and social function in adolescents with eczema: a population-based study","volume":"134","author":"Halvorsen","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2019.10.019_bib13","doi-asserted-by":"crossref","first-page":"e012637","DOI":"10.1136\/bmjopen-2016-012637","article-title":"Mental health associations with eczema, asthma and hay fever in children: a cross-sectional survey","volume":"6","author":"Hammer-Helmich","year":"2016","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.019_bib14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaci.2009.10.055","article-title":"Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus)","volume":"125","author":"Schmitt","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.jaad.2019.10.019_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.alit.2018.02.009","article-title":"Severity of eczema and mental health problems in Japanese schoolchildren: the ToMMo Child Health Study","volume":"67","author":"Kuniyoshi","year":"2018","journal-title":"Allergol Int"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.019_bib16","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.amepre.2015.07.029","article-title":"Utilization of preventive health care in adults and children with eczema","volume":"50","author":"Strom","year":"2016","journal-title":"Am J Prevent Med"},{"issue":"165","key":"10.1016\/j.jaad.2019.10.019_bib17","first-page":"1","article-title":"Design and estimation for the national health interview survey, 2006-2015","volume":"2","author":"Parsons","year":"2014","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.jaad.2019.10.019_bib18","series-title":"Survey Description, National Health Interview Survey, 2017","author":"National Center for Health Statistics","year":"2018"},{"issue":"11","key":"10.1016\/j.jaad.2019.10.019_bib19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00004583-200111000-00015","article-title":"Psychometric properties of the strengths and difficulties questionnaire","volume":"40","author":"Goodman","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.jaad.2019.10.019_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.chi.0000159157.57075.c8","article-title":"The Strengths and Difficulties Questionnaire: U.S. normative data and psychometric properties","volume":"44","author":"Bourdon","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.jaad.2019.10.019_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/mpr.1471","article-title":"Estimating the prevalence of any impairing childhood mental disorder in the national health interview survey","volume":"24","author":"Ringeisen","year":"2015","journal-title":"Int J Methods Psychiatr Res"},{"issue":"6","key":"10.1016\/j.jaad.2019.10.019_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.smrv.2010.01.004","article-title":"Eczema and sleep and its relationship to daytime functioning in children","volume":"14","author":"Camfferman","year":"2010","journal-title":"Sleep Med Rev"},{"issue":"3","key":"10.1016\/j.jaad.2019.10.019_bib23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1398-9995.2010.02487.x","article-title":"Infant eczema, infant sleeping problems, and mental health at 10 years of age: the prospective birth cohort study LISAplus","volume":"66","author":"Schmitt","year":"2011","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.019_bib24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaad.2017.08.043","article-title":"Sleep disturbance in children with moderate\/severe atopic dermatitis: a case-control study","volume":"78","author":"Fishbein","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.10.019_bib25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.det.2005.05.019","article-title":"Psychoneuroimmunodermatology of atopic dermatitis: from empiric data to the evolutionary hypothesis","volume":"23","author":"Pallanti","year":"2005","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.jaad.2019.10.019_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2340\/00015555-1188","article-title":"Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates","volume":"92","author":"Suarez","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.019_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jpepsy\/jsm076","article-title":"Review of the literature: integrating psychoneuroimmunology into pediatric chronic illness interventions","volume":"33","author":"Nassau","year":"2008","journal-title":"J Pediatr Psychol"},{"issue":"6","key":"10.1016\/j.jaad.2019.10.019_bib28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1017\/S0033291712001754","article-title":"Severity and persistence of asthma and mental health: a birth cohort study","volume":"43","author":"Goodwin","year":"2013","journal-title":"Psychol Med"},{"issue":"7","key":"10.1016\/j.jaad.2019.10.019_bib29","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.rmed.2012.03.021","article-title":"Mental health among adults with asthma and chronic bronchitis. A population-based study in Spain","volume":"106","author":"de Miguel Diez","year":"2012","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.019_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jpeds.2014.10.005","article-title":"Health-related quality of life and asthma among United States adolescents","volume":"166","author":"Cui","year":"2015","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.jaad.2019.10.019_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.anai.2018.03.028","article-title":"The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents: a literature review","volume":"121","author":"Blaiss","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2019.10.019_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2500\/aap2008.29.3072","article-title":"Pediatric allergic rhinitis: physical and mental complications","volume":"29","author":"Blaiss","year":"2008","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.jaad.2019.10.019_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaac.2015.02.005","article-title":"Depressive and anxiety symptom trajectories from school age through young adulthood in samples with autism spectrum disorder and developmental delay","volume":"54","author":"Gotham","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.jaad.2019.10.019_bib34","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1377","article-title":"Anxiety and mood disorder in children with autism spectrum disorder and ADHD","volume":"141","author":"Gordon-Lipkin","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.jaad.2019.10.019_bib35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/DER.0000000000000418","article-title":"Atopic dermatitis and hospitalization for mental health disorders in the United States","volume":"30","author":"Hsu","year":"2019","journal-title":"Dermatitis"},{"issue":"4","key":"10.1016\/j.jaad.2019.10.019_bib36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/CHI.0b013e3181985068","article-title":"Strengths and difficulties questionnaire as a dimensional measure of child mental health","volume":"48","author":"Goodman","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.jaad.2019.10.019_bib37","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/bjd.14031","article-title":"Assessment of atopic dermatitis using self-report and caregiver report: a multicentre validation study","volume":"173","author":"Silverberg","year":"2015","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219329020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219329020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:54:12Z","timestamp":1759272852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219329020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0190962219329020"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.10.019","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mental health impairment among children with atopic dermatitis: A United States population-based cross-sectional study of the 2013-2017 National Health Interview Survey","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}